Metastatic malignant neoplasm in the liver
Clinical trials for Metastatic malignant neoplasm in the liver explained in plain language.
Never miss a new study
Get alerted when new Metastatic malignant neoplasm in the liver trials appear
Sign up with your email to follow new studies for Metastatic malignant neoplasm in the liver, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink Hard-to-Treat neuroendocrine liver tumors
Disease control CompletedThis phase 2 pilot study tests whether combining the immunotherapy drug pembrolizumab (Keytruda) with liver-directed treatments (like embolization or radiation) or peptide receptor radionuclide therapy (PRRT) can shrink tumors in people with well-differentiated neuroendocrine tum…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LIVER
Phase 2 • Sponsor: Nicholas Fidelman, MD • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Zapping tumors with precision radiation may help control limited metastatic breast cancer
Disease control CompletedThis study looked at whether adding focused radiation (SBRT) or surgery to standard treatments like chemo or hormone therapy helps people with breast cancer that has spread to just one or two places. 129 participants were randomly assigned to get standard care alone or standard c…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LIVER
Phase 2/3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Double immunotherapy plus liver blockade targets eye cancer that spreads
Disease control CompletedThis trial investigates whether combining two immunotherapy drugs (ipilimumab and nivolumab) with a procedure called immunoembolization can help people whose uveal melanoma has spread to the liver. The drugs help the immune system attack cancer cells, while immunoembolization cut…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LIVER
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC